Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Metric
Company Name	Progyny, Inc.
Symbol	PGNY
MSH ID	COM:PROGYNY
Market	STOCKS
Sector	Healthcare
Industry	Medical - Healthcare Information Services
Country	US
Stage	Venture Round
Employee Count	563
Website	progyny.com
LinkedIn
Founders

Metric
Market Cap	2.60B
Enterprise Value
Monthly Web Traffic	317.48K
Web Traffic Growth	0.22
Valuation
Raised Capital	5M

Metric
Revenue	1.09B
Revenue (LTM)
Revenue (NTM)
Gross Profit	238.80M
EBITDA	64.47M
Operating Income	62.18M
Net Income	62.04M
EPS	0.62
Diluted EPS	0.62
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.22
Operating Profit Margin	0.06
EBITDA Margin	0.06
Net Profit Margin	0.06
Return on Equity	0.13
Return on Assets	0.09
Return on Capital Employed	0.15

COM:PROGYNY

Progyny, Inc.

Last Close

21.95

14/02 21:00

Market Cap

2.60B

Beta: -

Volume Today

918.67K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	71.39
P/B Ratio	7.20
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.28
EV Multiple	57.16

Metric
Days Sales Outstanding	94.97
Days Payables Outstanding	59.75
Days Inventory Outstanding	0.00
Operating Cycle	97.88
Cash Conversion Cycle	43.00
Asset Turnover	1.62

Metric
Operating Cash Flow	188.81M
Free Cash Flow	185.17M
Cash Flow to Debt	11.34
Operating Cash Flow/Sales	0.17
Free Cash Flow Yield	0.05

Metric
Cash & Equivalents	97.30M
Accounts Receivable	-21.74M
Inventory
Goodwill	11.88M
Debt to Capitalization	0.04
Debt to Assets	0.02
Current Ratio	3.16
Quick Ratio	3.31

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.12
R&D to Revenue
SG&A to Revenue	0.11